Clinical Trial Update: Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants [Phase 4]

View source ↗

Summary

Phase 4 trial update on oral nystatin prophylaxis to prevent systemic fungal infections in very low birth weight preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections Systemic

Drugs mentioned

• Nystatin (Nystatin)

Snippet

Sponsor: Dr Cipto Mangunkusumo General Hospital | Conditions: Fungal Infections Systemic | Phase 4 | Status: COMPLETED